Cita APA

Albanell, J., Martínez, M. T., Ramos, M., O´Connor, M., Cruz Merino, L. d. l., Santaballa, A., & Rojo, F. (2022). Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2–advanced breast cancer: GEICAM/2014–12 (FLIPPER).

Citación estilo Chicago

Albanell, J., M. T. Martínez, M. Ramos, M. O´Connor, Luis de la Cruz Merino, A. Santaballa, y F. Rojo. Randomized Phase II Study of Fulvestrant Plus Palbociclib or Placebo in Endocrine-sensitive, Hormone Receptor-positive/HER2–advanced Breast Cancer: GEICAM/2014–12 (FLIPPER). 2022.

Cita MLA

Albanell, J., et al. Randomized Phase II Study of Fulvestrant Plus Palbociclib or Placebo in Endocrine-sensitive, Hormone Receptor-positive/HER2–advanced Breast Cancer: GEICAM/2014–12 (FLIPPER). 2022.